Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer

NCT00954278 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non Small Cell Lung

Interventions

DRUG: sorafenib

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]